Notes to the individual financial report as at 31 March 2023
Individual financial report according to IFRS as at 31 March 2023
AGM 02-06-2023
General meeting of warrant holders
Sales revenues for March 2023
Sofia, Bulgaria, April 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for March 2023 the Company recorded an increase in sales of 127% compared to the same month of the previous year, incl. 3% increase in domestic sales and 426% increase in export sales due to the low base in the previous period due to the collapse of sales in the main markets as a result of the conflict between Russia and Ukraine.
Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022
Financial statements FSC forms
2022 Annual Financial Statements - ESEF format
Sales revenues for February 2023
Sofia, Bulgaria, March 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for February 2023 the Company recorded an increase in sales of 20% compared to the same month of the previous year, incl. 41% increase in domestic sales and 10% increase in export sales.
For the first two months of 2023, sales increased by a total of 21%, incl. same level of domestic sales and 42% increase in export sales.